Sfoglia per AUTORE
RULLI E
Collezione AOU San Luigi di Orbassano
Items : 2
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis. in ESMO open / ESMO Open. 2018 Nov 1;3(6):e000327. doi: 10.1136/esmoopen-2018-000327. eCollection 2018.
2018
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Garassino MC; Kawaguchi T; Gregorc V; Rulli E; Ando M; Marsoni S; Isa SI; Novello S; Farina G; Barni S; Torri V; Cinquini M;
Individual patients data analysis (IPD) of three randomized studies comparing erlotinib (E) with chemotherapy (CT) in patients with advanced wild-type epidermal growth factor receptor (wtEGFR) non-small cell lung cancer (NSCLC) in Journal of Clinical Oncology
2015
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Torri V; Ando M; Rulli E; Floriani IC; Kawaguchi T; Isa S-C; Gregorc V; Novello S; Barni S; Cinquini M; Marsoni S; Farina G; Garassino MC;